.

New mRNA Vaccine Reduces Risk of Melanoma Recurrence After Surgery by 42%

Nubar Afeyan’s Company Tests Skin Cancer Vaccine: Risk of Recurrence Falls by 42%

Scientists Rejuvenate Cells by More Than 60 Years for the First Time

Next-Generation Catheter Developed to Examine Dangerous Plaques Inside Coronary Arteries

Science Corporation Implants Vision-Restoring Chip in First Patient With Stargardt Disease

Lund University receives $19.4 million NIH grant to develop Alzheimer’s blood test